Antithrombotic Therapy for Inferior Vena Cava Stenting of Malignant Inferior Vena Cava Syndrome: A Questionnaire Study of Japan Interventional Radiology Study Group (JIVROSG)
The Arab Journal of Interventional Radiology · 01.07.2024 · 08 (02) · 096-099
DOI: 10.1055/s-0044-1782693 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Arab Journal of Interventional Radiology, erschienen am 01.07.2024. Verfasst von Mizuki Ozawa und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: National Cancer Center under the National Cancer Center Research and Development Fund.
Abstract (Originalsprache)
Purpose
The aim of this study was to evaluate the differences in antithrombotic therapy policies for inferior vena cava (IVC) stent placement among institutions and interventional radiologists in Japan. Materials and Methods The cross-sectional online-based questionnaire was conducted between December 2022 and January 2023, and a total of 114 institutions were included in this study. The questionnaire contained eight questions that were grouped into three sections: (1) whether IVC stents have been performed or not, (2) the number of IVC stent placements, and (3) the basic strategy of antithrombotic therapy for pre-, intra-, and post-IVC stent placement.
Results
Of the 114 institutions, 38 responses (33%) were collected. Twenty-four of the 38 institutions (63%) had performed IVC stent placement during the study period. The mean number of IVC stent placements during the study period was 3.4 cases per institution. The most frequently selected antithrombotic therapeutic strategies pre-, intra-, and post-stenting were no antithrombotic therapy (62.5%), anticoagulation therapy (54.2%), and no antithrombotic therapy (41.7%).
Conclusion
This study has revealed there is no consensus regarding antithrombotic therapy for IVC stent placement in Japan. The results of this studymay contribute to our understanding of the status of antithrombotic therapy for IVC stent placement. Future prospective studies are warranted to clarify the periprocedural antithrombotic therapy for IVC stent placement.
Förderung
- National Cancer Center under the National Cancer Center Research and Development Fund
Zitieren
APA
Ozawa, M., Sone, M., Sugawara, S., Arai, Y., & Kusumoto, M. (2024). Antithrombotic Therapy for Inferior Vena Cava Stenting of Malignant Inferior Vena Cava Syndrome: A Questionnaire Study of Japan Interventional Radiology Study Group (JIVROSG). The Arab Journal of Interventional Radiology, 08(02), 096-099. https://doi.org/10.1055/s-0044-1782693
Vancouver
Ozawa M, Sone M, Sugawara S, Arai Y, Kusumoto M. Antithrombotic Therapy for Inferior Vena Cava Stenting of Malignant Inferior Vena Cava Syndrome: A Questionnaire Study of Japan Interventional Radiology Study Group (JIVROSG). The Arab Journal of Interventional Radiology. 2024;08(02):096-099. doi:10.1055/s-0044-1782693
BibTeX
@article{Ozawa2024,
author = {Ozawa, Mizuki and Sone, Miyuki and Sugawara, Shunsuke and Arai, Yasuaki and Kusumoto, Masahiko},
title = {Antithrombotic Therapy for Inferior Vena Cava Stenting of Malignant Inferior Vena Cava Syndrome: A Questionnaire Study of Japan Interventional Radiology Study Group (JIVROSG)},
journal = {The Arab Journal of Interventional Radiology},
year = {2024},
volume = {08},
number = {02},
pages = {096--099},
doi = {10.1055/s-0044-1782693}
}
EUVIMED